DELCATH SYSTEMS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
DELCATH SYSTEMS, INC. (DCTH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 53.49 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-06
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 50.90K shares, a 6376.34% increase year-over-year.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 2.58K shares.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 2.59K shares, a 94.83% decline year-over-year.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 62.39K shares, a 526.77% increase year-over-year.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 65.76K shares, a 38.49% decline from fiscal 2024.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 106.91K shares, a 24.21% decline from fiscal 2023.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 141.06K shares, a 114.73% increase from fiscal 2022.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 65.69K shares, a 16657.65% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 50.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 53.49K shares 10-Q · filed 2026-08-06 | 56.07K shares derived: sum of 3 quarters · filed 2026-08-06 | 118.46K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 2.58K shares 10-Q · filed 2026-05-07 | 5.17K shares derived: sum of 2 quarters · filed 2026-05-07 | 67.56K shares derived: sum of 3 quarters · filed 2026-05-07 | 68.34K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 2.59K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 64.97K shares derived: sum of 2 quarters · filed 2026-02-26 | 65.76K shares derived: sum of 3 quarters · filed 2026-02-26 | 65.76K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 62.39K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 63.17K shares derived: sum of 2 quarters · filed 2025-11-04 | 63.17K shares 10-Q · filed 2025-11-04 | 113.17K shares derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | 786.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 786.00 shares 10-Q · filed 2025-08-06 | 50.79K shares derived: sum of 3 quarters · filed 2025-08-06 | 60.74K shares derived: sum of 4 quarters · filed 2025-08-06 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | 50.00K shares derived: sum of 2 quarters · filed 2025-05-08 | 59.95K shares derived: sum of 3 quarters · filed 2025-05-08 | 91.57K shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 50.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 59.95K shares derived: sum of 2 quarters · filed 2025-03-06 | 91.57K shares derived: sum of 3 quarters · filed 2025-03-06 | 106.91K shares 10-K · filed 2025-03-06 |
| 2024-09-30 | 9.95K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | 41.57K shares derived: sum of 2 quarters · filed 2024-11-08 | 56.91K shares 10-Q · filed 2024-11-08 | 82.20K shares derived: sum of 4 quarters · filed 2024-11-08 |
| 2024-06-30 | 31.61K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | 46.96K shares 10-Q · filed 2024-08-05 | 72.24K shares derived: sum of 3 quarters · filed 2024-08-05 | 112.24K shares derived: sum of 4 quarters · filed 2024-08-05 |
| 2024-03-31 | 15.34K shares 10-Q · filed 2024-05-14 | 40.63K shares derived: sum of 2 quarters · filed 2024-05-14 | 80.63K shares derived: sum of 3 quarters · filed 2024-05-14 | 105.33K shares derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | 25.29K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | 65.29K shares derived: sum of 2 quarters · filed 2024-03-26 | 89.99K shares derived: sum of 3 quarters · filed 2024-03-26 | 141.06K shares 10-K · filed 2024-03-26 |
| 2023-09-30 | 40.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 64.70K shares derived: sum of 2 quarters · filed 2023-11-13 | 115.77K shares 10-Q · filed 2023-11-13 | 144.83K shares derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | 24.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 75.77K shares 10-Q · filed 2023-08-09 | 104.83K shares derived: sum of 3 quarters · filed 2023-08-09 | 112.35K shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 51.07K shares 10-Q · filed 2023-05-22 | 80.14K shares derived: sum of 2 quarters · filed 2023-05-22 | 87.65K shares derived: sum of 3 quarters · filed 2023-05-22 | 110.11K shares derived: sum of 4 quarters · filed 2023-05-22 |
| 2022-12-31 | 29.06K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | 36.57K shares derived: sum of 2 quarters · filed 2023-03-27 | 59.04K shares derived: sum of 3 quarters · filed 2023-03-27 | 65.69K shares 10-K · filed 2023-03-27 |
| 2022-09-30 | 7.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 29.98K shares derived: sum of 2 quarters · filed 2022-11-08 | 36.63K shares 10-Q · filed 2022-11-08 | |
| 2022-06-30 | 22.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 29.12K shares 10-Q · filed 2022-08-08 | ||
| 2022-03-31 | 6.65K shares 10-Q · filed 2022-05-11 | |||
| 2021-12-31 | 392.00 shares 10-K · filed 2022-03-31 | |||
| 2014-12-31 | 45.67K shares 10-K · filed 2016-03-18 | |||
| 2013-12-31 | -3.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-18 | -3.13K shares derived: sum of 2 quarters · filed 2016-03-18 | 16.87K shares 10-K · filed 2016-03-18 | |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | 20.00K shares 10-Q · filed 2013-11-06 | ||
| 2013-06-30 | 20.00K shares 10-Q · filed 2013-08-06 | |||
| 2012-12-31 | 20.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13 | 20.00K shares derived: sum of 2 quarters · filed 2013-03-13 | 420.00K shares 10-K · filed 2013-03-13 | |
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | 400.00K shares 10-Q · filed 2012-11-07 | ||
| 2012-06-30 | 400.00K shares 10-Q · filed 2012-08-08 | |||
| 2011-12-31 | 120.00K shares 10-K · filed 2013-03-13 | |||
| 2010-12-31 | 120.00K shares 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| CARLSMED, INC. (CARL) | United States | $0.405B |